Sarm1 Deletion, but Not Wld, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
Authors:
Open Access
- 1 October 2017
- journal article
- Published by Elsevier in Cell Reports
- Vol. 21 (1) , 10-16
Abstract
No abstract availableKeywords
Funding Information
- Biotechnology and Biological Sciences Research Council
- Medical Research Council (MR/N004582/1)
This publication has 26 references indexed in Scilit:
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal DegenerationNeuron, 2017
- Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca2+ Influx but Only Modestly Influenced by MitochondriaCell Reports, 2015
- Wallerian degeneration: an emerging axon death pathway linking injury and diseaseNature Reviews Neuroscience, 2014
- A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosisHuman Molecular Genetics, 2013
- Rescue of Peripheral and CNS Axon Defects in Mice Lacking NMNAT2Journal of Neuroscience, 2013
- Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR InteractionsThe Journal of Neuroscience, 2013
- Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJNeurobiology of Disease, 2013
- Differential protection of neuromuscular sensory and motor axons and their endings in Wld mutant miceNeuroscience, 2012
- Non-Nuclear WldSDetermines Its Neuroprotective Efficacy for Axons and SynapsesIn VivoJournal of Neuroscience, 2009
- Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric geneNature Neuroscience, 2001